On Friday, Tarsus Pharmaceuticals Inc (NASDAQ: TARS) opened higher 13.72% from the last session, before settling in for the closing price of $23.61. Price fluctuations for TARS have ranged from $12.57 to $42.50 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -17.43%. Company’s average yearly earnings per share was noted 21.43% at the time writing. With a float of $31.25 million, this company’s outstanding shares have now reached $34.21 million.
Let’s determine the extent of company efficiency that accounts for 244 employees.
Tarsus Pharmaceuticals Inc (TARS) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Tarsus Pharmaceuticals Inc is 17.86%, while institutional ownership is 100.14%. The most recent insider transaction that took place on Jun 18 ’24, was worth 286,924. In this transaction an insider of this company sold 10,445 shares at a rate of $27.47, taking the stock ownership to the 18,136 shares. Before that another transaction happened on Mar 18 ’24, when Company’s President/CEO and Board Chair sold 10,415 for $30.60, making the entire transaction worth $318,699. This insider now owns 26,456 shares in total.
Tarsus Pharmaceuticals Inc (TARS) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.88 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 21.43% per share during the next fiscal year.
Tarsus Pharmaceuticals Inc (NASDAQ: TARS) Trading Performance Indicators
Check out the current performance indicators for Tarsus Pharmaceuticals Inc (TARS). In the past quarter, the stock posted a quick ratio of 6.99. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 12.25.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.48, a number that is poised to hit -0.87 in the next quarter and is forecasted to reach -1.98 in one year’s time.
Technical Analysis of Tarsus Pharmaceuticals Inc (TARS)
Looking closely at Tarsus Pharmaceuticals Inc (NASDAQ: TARS), its last 5-days average volume was 1.34 million, which is a jump from its year-to-date volume of 0.72 million. As of the previous 9 days, the stock’s Stochastic %D was 60.85%. Additionally, its Average True Range was 1.99.
During the past 100 days, Tarsus Pharmaceuticals Inc’s (TARS) raw stochastic average was set at 30.19%, which indicates a significant decrease from 74.15% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 91.85% in the past 14 days, which was higher than the 60.53% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $27.98, while its 200-day Moving Average is $27.43. However, in the short run, Tarsus Pharmaceuticals Inc’s stock first resistance to watch stands at $28.12. Second resistance stands at $29.38. The third major resistance level sits at $30.77. If the price goes on to break the first support level at $25.47, it is likely to go to the next support level at $24.08. Should the price break the second support level, the third support level stands at $22.82.
Tarsus Pharmaceuticals Inc (NASDAQ: TARS) Key Stats
There are currently 37,782K shares outstanding in the company with a market cap of 1.02 billion. Presently, the company’s annual sales total 17,450 K according to its annual income of -135,890 K. Last quarter, the company’s sales amounted to 27,610 K and its income totaled -35,730 K.
